Sab Biotherapeutics, Inc. · NASDAQ:SABS
Woodline Partners LP reported a 6.80% stake in Sab Biotherapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Woodline Partners LP reported a 6.80% stake in Sab Biotherapeutics, Inc., 5,455,355 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 6.80%
- Shares
- 5,455,355
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Woodline Partners LP | 6.80% | 5,455,355 |
Source
Related
- Sab Biotherapeutics, Inc.
- Woodline Partners LP
- Sab Biotherapeutics, Inc. shareholders
- Schedule 13G · Woodline Partners LP · Nov 14, 2025
- Form 4 · Kropotova Alexandra · Sep 18, 2026
- Schedule 13G/A · Vivo Opportunity, LLC · Aug 14, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Aug 14, 2026
- Schedule 13G/A · Caligan Partners LP · Aug 14, 2026
- Schedule 13G/A · Commodore Capital LP · Aug 14, 2026